Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating CKD-386 for efficacy and safety in patients with dyslipidemia and hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypertension

Drugs mentioned

• CKD-386

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Dyslipidemia Patients With Hypertension | Phase 3 | Status: COMPLETED